Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Assess, compare and enhance the status of Persons with Multiple Sclerosis (MS) in Europe: a European Register for MS.
Theranostic implications of nanotechnology in multiple sclerosis: a future perspective.
Disseminated cryptococcosis in a patient with multiple sclerosis treated with fingolimod.
Fingolimod targeting protein phosphatase 2A differently affects IL-33 induced IL-2 and IFN-γ production in CD8(+) lymphocytes.
Markers of oxidative stress in plasma and saliva in patients with multiple sclerosis.
Neuroscience. To learn is to myelinate.
Chronic oligodendrogenesis and remyelination after spinal cord injury in mice and rats.
Framework for Assessment of the Usability of Lower-Extremity Robotic Exoskeletal Orthoses.
Epidemiology of amyotrophic lateral sclerosis in Isfahan, Iran.
Consequences of NMO-IgG binding to aquaporin-4 in neuromyelitis optica.
[Basic mechanisms of action of fingolimod in relation to multiple sclerosis].
Multiple sclerosis: clinical features and MRI findings in Northern China.
Copaiba Oil Suppresses Inflammatory Cytokines in Splenocytes of C57Bl/6 Mice Induced with Experimental Autoimmune Encephalomyelitis (EAE).
The relation between peptide hormones and sex hormone in patients with multiple sclerosis.
Bupropion-Related Visual Hallucinations in a Veteran With Posttraumatic Stress Disorder and Multiple Sclerosis.
Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study.
The first 10 years with multiple sclerosis: The longitudinal course of daily functioning.
The discovery of natalizumab, a potent therapeutic for multiple sclerosis.
Effect of stress on brain inflammation and multiple sclerosis.
The radiologically isolated syndrome.
CD14 is a key organizer of microglial responses to CNS infection and injury.
Neuroimaging-evident lesional pathology associated with REM sleep behavior disorder.
Biological relevance of citrullinations: diagnostic, prognostic and therapeutic options.
The pathogenic role of the inflammasome in neurodegenerative diseases.
Sulfatides in extracellular vesicles isolated from plasma of multiple sclerosis patients.
Pages
« first
‹ previous
…
264
265
266
267
268
269
270
271
272
…
next ›
last »